Study S001570

Genetics of the Acute Response to Oral Semaglutide (GAROS)

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT05340868
Acronym: GAROS
Study type: INTERVENTIONAL
Masking: NONE
Status: RECRUITING
Enrollment: 1000
Start: 2022-09-01
Primary completion: 2025-12-31
Lead sponsor: Medical University of Bialystok
Conditions: PreDiabetes; Prediabetic State; Obesity
Interventions: DRUG:Semaglutide Pill
Results posted: FALSE
Individual participant data sharing: YES

Registered primary outcomes

Glycemic measures - change in HbA1c (%) [1 and 3 months]
Body composition - change in body weight (kg) [1 and 3 months]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.